# Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis

> **NCT02786017** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Decompensated Cirrhosis

## Interventions

- **BIOLOGICAL:** Conventional therapy
- **BIOLOGICAL:** Injectable Collagen Scaffold + HUC-MSCs

## Key facts

- **NCT ID:** NCT02786017
- **Lead sponsor:** Chinese Academy of Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02786017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02786017, "Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02786017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*